Allogeneic and Autologous Anti-CD7 CAR-T Cell Therapies in Relapsed or Refractory T Cell Malignancies

被引：2
|
作者：
Zhang, Yinqiang [1 ,2 ]
Li, Chenggong [1 ,2 ]
Jiang, Huiwen [1 ,2 ]
Luo, Wenjing [1 ,2 ]
Du, Mengyi [1 ,2 ]
Zhou, Fen [1 ,3 ]
Tang, Lu [1 ,2 ]
Wu, Jianghua [1 ,2 ]
Wei, Qiuzhe [1 ,2 ]
Lu, Cong [1 ,2 ]
Kou, Haiming [1 ,2 ]
Wu, Di [4 ]
Alex, Chang H. [5 ]
Mei, Heng [1 ,2 ]
Hu, Yu [1 ,2 ]
机构：
[1] Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Peoples R China
[4] Beijing GoBrd Hosp Management Co Ltd, Beijing, Peoples R China
[5] Shanghai YaKe Biotechnol Ltd, Shanghai, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170819
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4592 / 4594
页数：3
相关论文
共 50 条
  • [1] Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies
    Zhang, Yinqiang
    Li, Chenggong
    Du, Mengyi
    Jiang, Huiwen
    Luo, Wenjing
    Tang, Lu
    Kang, Yun
    Xu, Jia
    Wu, Zhuolin
    Wang, Xindi
    Huang, Zhongpei
    Zhang, Yanlei
    Wu, Di
    Chang, Alex H. H.
    Hu, Yu
    Mei, Heng
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [2] Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies
    Yinqiang Zhang
    Chenggong Li
    Mengyi Du
    Huiwen Jiang
    Wenjing Luo
    Lu Tang
    Yun Kang
    Jia Xu
    Zhuolin Wu
    Xindi Wang
    Zhongpei Huang
    Yanlei Zhang
    Di Wu
    Alex H. Chang
    Yu Hu
    Heng Mei
    Blood Cancer Journal, 13
  • [3] Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy
    Zhu, Haibo
    Deng, Haobin
    Mu, Juan
    Lyu, Cuicui
    Jiang, Yanyu
    Deng, Qi
    ONCOTARGETS AND THERAPY, 2021, 14 : 4023 - 4037
  • [4] Phase 1 Dose Escalation Study of the Anti-CD7 CAR-T Therapy in Relapsed/Refractory T-Cell Acute Leukemia and Lymphoblastic Lymphoma
    Cheng, Jiali
    Wang, Jue
    Mao, Xia
    Mu, Wei
    Sun, Shijia
    Zhou, Xiaoxi
    Huang, Liang
    BLOOD, 2023, 142
  • [5] Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
    Ramos, Carlos A.
    Grover, Natalie S.
    Beaven, Anne W.
    Lulla, Premal D.
    Wu, Meng-Fen
    Ivanova, Anastasia
    Wang, Tao
    Shea, Thomas C.
    Rooney, Cliona M.
    Dittus, Christopher
    Park, Steven I.
    Gee, Adrian P.
    Eldridge, Paul W.
    McKay, Kathryn L.
    Mehta, Birju
    Cheng, Catherine J.
    Buchanan, Faith B.
    Grilley, Bambi J.
    Morrison, Kaitlin
    Brenner, Malcolm K.
    Serody, Jonathan S.
    Dotti, Gianpietro
    Heslop, Helen E.
    Savoldo, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) : 3794 - +
  • [6] CAR-T cell combination therapies in hematologic malignancies
    Zhou, Delian
    Zhu, Xiaojian
    Xiao, Yi
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [7] Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells
    Xie, Leling
    Gu, Runxia
    Yang, Xue
    Qiu, Shaowei
    Xu, Yingxi
    Mou, Junli
    Wang, Ying
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    BLOOD, 2022, 140 : 4535 - 4535
  • [8] Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells
    Xie, Leling
    Gu, Runxia
    Yang, Xue
    Qiu, Shaowei
    Xu, Yingxi
    Mou, Junli
    Wang, Ying
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    HUMAN GENE THERAPY, 2023, 34 (23-24) : 1257 - 1272
  • [9] CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma
    Su, Lihe
    Wu, Lan
    Lobb, Roy R.
    Rennert, Paul D.
    Ambrose, Christine
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [10] CAR-T ENGAGER PROTEINS OPTIMIZE ANTI-CD19 CAR-T CELL THERAPIES FOR LYMPHOMA
    Rennert, Paul
    Su, Lihe
    Wu, Lan
    Lobb, Roy
    Ambrose, Christine
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A187 - A187
12345